Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Philip Bredin
Observed names:
P. Bredin,
Philip Hugh Bredin
Institutions:
Royal College of Surgeons in Ireland,
Cork University Hospital,
St. Vincent's University Hospital
Observed institutions:
Royal College of Surgeons in Ireland,
University College Cork,
Beaumont Hospital,
Cork University Hospital,
Eastern Health,
St. Vincent's University Hospital,
Beaumont Hospital, Dearborn
show all 7
ORCID:
0000-0003-2560-8699
Observed ORCID:
0000-0003-2560-8699
OpenAlex ID:
A5008182018
Systemic therapy for metastatic HER2-positive breast cancer
2020
·
Philip Bredin
, Janice M. Walshe
, et al.
·
Seminars in Oncology
·
81
KMT2C and KMT2D aberrations in breast cancer
2024
·
Emily Tinsley
, Philip Bredin
, et al.
·
Trends in cancer
·
38
Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study)
2024
·
Gavin P. Dowling
, Sinead Toomey
, et al.
·
BMC Cancer
·
32
PDF
The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer
2022
·
Philip Bredin
, Jarushka Naidoo
·
Cancer and Metastasis Reviews
·
29
PDF
Why We Should, and How We Can, Reduce the Climate Toxicity of Cancer Care
2024
·
Emer Lynch
, Philip Bredin
, et al.
·
JCO Oncology Practice
·
8
Study protocol: LIAM Mc trial (Linking In with Advice and supports for Men impacted by Metastatic cancer)
2025
·
Brendan Noonan
, Philip Bredin
, et al.
·
PLoS ONE
·
3
PDF
Correction to: The gut microbiome, immune check point inhibition and immune‑related adverse events in non‑small cell lung cancer
2022
·
Philip Bredin
, Jarushka Naidoo
·
Cancer and Metastasis Reviews
·
2
PDF
Contrasting roles of KMT2C and KMT2D in breast cancer
2025
·
Emily Tinsley
, Philip Bredin
, et al.
·
Scientific Reports
·
1
PDF
Dose Adjusted Neoadjuvant Paclitaxel, Carboplatin, Trastuzumab and Pertuzumab in Women With HER2 Positive Early Breast Cancer
2025
·
Carolyn Moloney-Lineen
, Maggie O’Connor
, et al.
·
Clinical Breast Cancer
·
1
Visceral Perforation Complicating BRAF/MEK Targeted Therapy of Papillary Thyroid Carcinoma with Anaplastic Areas
2024
·
Simon Louis Barry
, Emer Lynch
, et al.
·
Onco
·
1
Greening Ireland’s oncology practice: Reducing climate toxicity and improving sustainability in a national chemotherapy formulary.
2024
·
Emer Lynch
, Philip Hugh Bredin
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Neoadjuvant quadruplet chemotherapy PAXG for pancreatic cancer
2025
·
Philip Bredin
, Bas Groot Koerkamp
, et al.
·
The Lancet
232P Impact of the addition of carboplatin and pembrolizumab to neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC): A large, retrospective, two-centre, real-world study
2025
·
K. Weiner Gorzel
, O.M. Kell
, et al.
·
ESMO Open
PDF
Role of immunotherapy in managing cancers prior to liver transplantation
2024
·
Philip Bredin
, Zita Galvin
, et al.
·
Current Opinion in Organ Transplantation
Abstract PO5-01-02: A retrospective review of pathological complete response and toxicity rates to a modified version of TCHP (Paclitaxel, Trastuzumab, Pertuzumab, Carboplatin) for HER2 positive breast cancer stage II and III
2024
·
Carolyn Moloney
, Maggie Louise O'Connor
, et al.
·
Cancer Research
1746P Unintended consequences: Working time directives and oncology staff implications
2023
·
S. Barry
, M.L. O'Connor
, et al.
·
Annals of Oncology
PDF
21P Implications of KMT2C knockdown for DNA damage repair in breast cancer
2023
·
P. Bredin
, S. Toomey
, et al.
·
Annals of Oncology
PDF
P59.23 Biomarker Testing for Non-Small Cell Lung Cancer at a Tertiary Referral Hospital in Ireland: Challenges and Opportunities
2021
·
P. Bredin
, O. Breathnach
, et al.
·
Journal of Thoracic Oncology
PDF
1599P Vaccination in the COVID-19 era: Attitudes amongst oncology patients
2021
·
S. Horan
, C. Murphy
, et al.
·
Annals of Oncology
PDF
1728P Clinical practice audit on prescribing frequency of buccal midazolam in patients with high grade gliomas
2021
·
A. Reilly
, C. Quinn
, et al.
·
Annals of Oncology
1637P Unintended consequences for an integrated oncology ecosystem from COVID adaptations
2021
·
P. Bredin
, C. Murphy
, et al.
·
Annals of Oncology
212P_PR Language and understanding: The complexity of insight in cancer care
2021
·
T. Martin
, D. O'Doherty
, et al.
·
Journal of Thoracic Oncology
Small bowel adenocarcinoma treatment: A single centre experience.
2017
·
Philip Bredin
, Joseph J McKendrick
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
23
Citation count:
197
H-index:
5
I10-index:
4
Year
Topic
Type